75 results
8-K
EX-99.2
EVOK
Evoke Pharma Inc
14 Jan 21
Evoke Pharma Announces Proposed Public Offering of Common Stock
5:22pm
to satisfaction of customary closing conditions.
Laidlaw & Company (UK) Ltd. is acting as sole book-running manager for the offering.
Evoke intends to use … with market conditions and the satisfaction of customary closing conditions related to the proposed public offering and other risks and uncertainties
8-K
EX-99.1
EVOK
Evoke Pharma Inc
20 Jul 16
Evoke Pharma Announces $4.5 Million At-The-Market Offering
12:00am
of the offering is expected to take place on or about July 25, 2016, subject to the satisfaction of customary closing conditions.
In connection with the offering … to the risks and uncertainties associated with market conditions and the satisfaction of customary closing conditions related to the offering
8-K
EX-99.1
EVOK
Evoke Pharma Inc
9 Feb 24
Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 Million
5:15pm
to satisfaction of customary closing conditions.
Craig-Hallum and Laidlaw & Company (UK) Ltd. are acting as joint book-running managers for the offering … to the risks and uncertainties associated with market conditions and the satisfaction of customary closing conditions related to the proposed public
8-K
EX-99.1
EVOK
Evoke Pharma Inc
14 Jan 21
Evoke Pharma Announces Proposed Public Offering of Common Stock
5:22pm
forth in this press release due to the risks and uncertainties associated with market conditions and the satisfaction of customary closing conditions
8-K
ye83bzz o90qri4
2 Dec 14
Changes in Registrant's Certifying Accountant
12:00am
8-K
0hc4btbitygx
14 Jan 21
Evoke Pharma Announces Proposed Public Offering of Common Stock
5:22pm
8-K
hcvp7h
14 Feb 24
Unregistered Sales of Equity Securities
9:00am
8-K
tegfnr0ro2hy7q6yh9ry
9 Feb 24
Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 Million
5:15pm
8-K
mw8edumrx 8nz
23 Dec 20
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
28ogj779p c2b93msy9
12 May 21
Results of Operations and Financial Condition
4:16pm
8-K
fsr2fj eobqi
20 Jul 16
Evoke Pharma Announces $4.5 Million At-The-Market Offering
12:00am
8-K
EX-10.1
eudww5bp wxd
11 May 23
Departure of Directors or Certain Officers
4:00pm
10-K
EX-10.13
5h67lniu
25 Mar 14
Annual report
12:00am
8-K
EX-10.1
v90qsf7kbkdjenclbi
20 Jul 16
Evoke Pharma Announces $4.5 Million At-The-Market Offering
12:00am